In Southeast Asia, 36 percent of the drug samples tested were judged to be counterfeit, as were 20 percent of the drug samples in sub - Saharan Africa.
Kagu - Aasias kuulutati võltsituks 36 protsenti testitud ravimeist ning Sahara - taguses Aafrikas 20 protsenti.